newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit

In person presentation today, Thursday, June 5th at 9:30 AM ET to discuss Company's lead program, TPI 287, in development for treatment of glioblastoma multiforme HOUSTON, TX / ACCESS Newswire / June 5, 2025 / CNS